Mendelsohn J - Search Results

1

From combinatorial peptide selection to drug prototype (II): targeting the epidermal growth factor receptor pathway.

Cardó-Vila M, Giordano RJ, Sidman RL, Bronk LF, Fan Z, Mendelsohn J, Arap W, Pasqualini R. Cardó-Vila M, et al. Among authors: mendelsohn j. Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5118-23. doi: 10.1073/pnas.0915146107. Epub 2010 Feb 26. Proc Natl Acad Sci U S A. 2010. PMID: 20190183 Free PMC article.

2

Therapeutic application of anti-growth factor receptor antibodies.

Fan Z, Mendelsohn J. Fan Z, et al. Among authors: mendelsohn j. Curr Opin Oncol. 1998 Jan;10(1):67-73. doi: 10.1097/00001622-199801000-00011. Curr Opin Oncol. 1998. PMID: 9466487 Review.

3

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab.

Lu Y, Li X, Liang K, Luwor R, Siddik ZH, Mills GB, Mendelsohn J, Fan Z. Lu Y, et al. Among authors: mendelsohn j. Cancer Res. 2007 Sep 1;67(17):8240-7. doi: 10.1158/0008-5472.CAN-07-0589. Cancer Res. 2007. PMID: 17804738

4

Requirement of hypoxia-inducible factor-1alpha down-regulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab.

Li X, Lu Y, Liang K, Pan T, Mendelsohn J, Fan Z. Li X, et al. Among authors: mendelsohn j. Mol Cancer Ther. 2008 May;7(5):1207-17. doi: 10.1158/1535-7163.MCT-07-2187. Mol Cancer Ther. 2008. PMID: 18483308

5

Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225.

Ye D, Mendelsohn J, Fan Z. Ye D, et al. Among authors: mendelsohn j. Oncogene. 1999 Jan 21;18(3):731-8. doi: 10.1038/sj.onc.1202319. Oncogene. 1999. PMID: 9989823

6

Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.

Ye D, Mendelsohn J, Fan Z. Ye D, et al. Among authors: mendelsohn j. Clin Cancer Res. 1999 Aug;5(8):2171-7. Clin Cancer Res. 1999. PMID: 10473102

7

The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.

Luwor RB, Lu Y, Li X, Mendelsohn J, Fan Z. Luwor RB, et al. Among authors: mendelsohn j. Oncogene. 2005 Jun 23;24(27):4433-41. doi: 10.1038/sj.onc.1208625. Oncogene. 2005. PMID: 15806152

8

Epidermal growth factor receptor family and chemosensitization.

Mendelsohn J, Fan Z. Mendelsohn J, et al. J Natl Cancer Inst. 1997 Mar 5;89(5):341-3. doi: 10.1093/jnci/89.5.341. J Natl Cancer Inst. 1997. PMID: 9060954 Review. No abstract available.

9

Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody.

Liu B, Fang M, Lu Y, Mendelsohn J, Fan Z. Liu B, et al. Among authors: mendelsohn j. Oncogene. 2001 Apr 5;20(15):1913-22. doi: 10.1038/sj.onc.1204277. Oncogene. 2001. PMID: 11313939

10

In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang K, Mendelsohn J, Fan Z. Milas L, et al. Among authors: mendelsohn j. Clin Cancer Res. 2000 Feb;6(2):701-8. Clin Cancer Res. 2000. PMID: 10690556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters